off-label use of glp-1 agonists for obesity in 2016 Prescribing patterns glucagon-like peptide-1 receptor the Swedish capital region—a register-based cross-sectional study | European Journal of Clinical Pharmacology Emergency Presentations of GLP-1 Agonist
Description
Given the heterogeneity of study designs and outcomes, results were synthesized using a narrative approach
Reference Nieto LM et al
Common side effects of Trulicity include nausea, diarrhea, vomiting, stomach pain, decreased appetite, indigestion, and/or fatigue
Acute pancreatitis has been reported in connection with GLP-1 RAs use [121, 124,125,126], though the data are insufficient to establish a causal relationship
